GLP1R and familial pancreatic carcinoma: Surprisingly, our previous studies revealed that higher level of GLP-1 receptor in PDAC tissue was associated with better prognosis in patients with PDAC after surgery, and that the GLP-1 receptor agonist liraglutide had an anti-tumor effect on human pancreatic cancer cells both in vitro and in vivo [12,13].